Trending...
- MahoganyBooks Celebrates 2nd Annual Black Books Matter Day
- Arch Amenities Group Acquires Pool Management and Construction Company
- Maryland Tech Council Seeks Technologies that Enable Diversity, Equity, and Inclusivity Strategies in the Workplace
SAN JOSE, Calif. - Marylandian -- CPC Scientific Inc., a leading global peptide CRDMO (Contract Research, Development, and Manufacturing Organization) has invested in a new peptide API (Active Pharmaceutical Ingredient) manufacturing site, bringing many new jobs to Rocklin, California. The 41,000 sq ft facility located at 3880 Atherton Rd, Rocklin, CA 95765 will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity and will diversify CPC Scientific's supply chain.
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on Marylandian
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on Marylandian
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on Marylandian
- Kinugawa Onsen Celebrates its 330th Anniversary AND Kawagoe City Celebrates its 100th Anniversary - Both with Fireworks!
- Anirban Basu Presents Economic Update for The Prosperity Consulting Group
- Celebrate Maryland Farmers' Market Week August 7-13
- VA Center of North County Hosts It's First Annual VANC Fest; an Art, Music and Culinary Experience
- 10 Years in the Making: #LatinaGeeks Celebrates 10th Anniversary with Inaugural Inspirada Awards & Fundraising Gala
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on Marylandian
- Downtown Brooklyn Gains A Mixed-Use Gem with The Brook, Financing Arranged by Walker & Dunlop
- 3i Solutions Announces New Leadership Brings a Customer-Focused Approach
- MahoganyBooks Celebrates 2nd Annual Black Books Matter Day
- Barcoding, Inc. Named a 2022 Great Supply Chain Partner
- Loving Cook Nook: Perfect Your Cooking Skills With The Proper Tools And Utensils
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
Source: CPC Scientific Inc.
Filed Under: Technology
0 Comments
Latest on Marylandian
- Maryland Horse Industry Board Accepting 2023 Grant Applications
- Century 21's The Gene Group Joins PalMar Studios as a Primary Partner on "Triangle Park," a Documentary on the NFL's First-Ever Game
- Inferno Phil's Outpost Introduces the Ice-Pron,The High-Tech BBQ Apron Along with Craft Hot Sauces
- Women of Color STEM Conference Announces 2022 List of Award Recipients
- Dr. Valerie Sheares Ashby is 2022 Women of Color Technologist of the Year
- Prince Oak Oakleyski has finished directing and already released his new film, the final episode of "Prince Oakleyski Is Enough". A non-profit movie
- Sinclair Announces Agreements with Korean Broadcasters to Further NextGen Broadcasting
- Precigen to Announce Second Quarter and First Half 2022 Financial Results on August 8th
- 3C Group to Distribute Certified Nutraceuticals' Functional Ingredients for Dietary Supplements in Thailand
- Maryland: MDA Secretary Bartenfelder Opens 2022 International Leadership Alumni Conference
- Calling All Witches: WitchFest 2022 Announced in Denver Colorado
- Maryland Tech Council Seeks Technologies that Enable Diversity, Equity, and Inclusivity Strategies in the Workplace
- Maryland: MDA Now Accepting Applications for Governor's Ag Hall of FameĀ
- Arch Amenities Group Acquires Pool Management and Construction Company
- New music from Sho Richardsin, 'The Win'
- JBG SMITH Declares a Quarterly Common Dividend of $0.225 Per Share
- Fashion Umbrella Foundation Prepares for 4th Annual Gala and Impact Awards
- Sharifah Hardie Launches Campaign to Raise $1.5B for Local Black Businesses
- Continuing To Champion Change for Mental Health Awareness and Suicide Prevention
- COPT Executes Build-to-Suit Lease with Defense Contractor at The National Business Park